Current Drug Targets
Title: Editorial [Hot Topic: Recent Strategies for Potentiation and Facilitation of Antidepressant Treatment (Guest Editor: Eliyahu Dremencov)]
Volume: 7 Issue: 2
Author(s): Eliyahu Dremencov
Affiliation:
Export Options
About this article
Cite this article as:
Dremencov Eliyahu, Editorial [Hot Topic: Recent Strategies for Potentiation and Facilitation of Antidepressant Treatment (Guest Editor: Eliyahu Dremencov)], Current Drug Targets 2006; 7 (2) . https://dx.doi.org/10.2174/138945006775515437
DOI https://dx.doi.org/10.2174/138945006775515437 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Proceedings of the Regional Conference of the International Society for Adolescent Psychiatry and Psychology (ISAPP), a Joint Conference with 18<sup>th</sup> National Symposium of Adolescent Mental Health, Ankara, Turkey, November 21-24, 2013<sup>1</sup>
Adolescent Psychiatry Safety and Tolerability of Agomelatine: Focus on Hepatotoxicity
Current Drug Metabolism Targeting the Neuronal Activity of Prefrontal Cortex: New Directions for the Therapy of Depression
Current Neuropharmacology Marginal Vitamin A Deficiency Exacerbates Memory Deficits Following Aβ1-42 Injection in Rats
Current Alzheimer Research Metabolic Basis of Polycystic Ovarian Syndrome; Indications for Biochemical Screening
Endocrine, Metabolic & Immune Disorders - Drug Targets CACNB2: An Emerging Pharmacological Target for Hypertension, Heart Failure, Arrhythmia and Mental Disorders
Current Molecular Pharmacology Discussion on Pharmacogenetic Interaction in G6PD Deficiency and Methods to Identify Potential Hemolytic Drugs
Cardiovascular & Hematological Disorders-Drug Targets Computer Aided Drug Design: Success and Limitations
Current Pharmaceutical Design [11C]Meta-Hydroxyephedrine PET/CT
Current Radiopharmaceuticals Alzheimers Disease (AD) and Mild Cognitive Impairment (MCI) Patients are Characterized by Increased BDNF Serum Levels
Current Alzheimer Research Mitochondria as a Target for Exercise-Induced Cardioprotection
Current Drug Targets Pharmacogenomics in Psychiatry: Implications for Practice
Recent Patents on Biotechnology Editorial [Hot Topic: T-Type Calcium Channels in Health and Disease (Guest Editor: Slobodan M. Todorovic)]
CNS & Neurological Disorders - Drug Targets Effects of Melatonin on Peripheral Nerve Regeneration
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery ABAD: A Potential Therapeutic Target for Aβ-Induced Mitochondrial Dysfunction in Alzheimers Disease
Mini-Reviews in Medicinal Chemistry Mood-Stabilizers Target the Brain Arachidonic Acid Cascade
Current Molecular Pharmacology HIV-1 Subtypes B and C Tat Differentially Impact Synaptic Plasticity Expression and Implicates HIV-Associated Neurocognitive Disorders§
Current HIV Research Psychotherapy for Pregnant Women with Schizophrenia
Current Women`s Health Reviews Transplantation of Undifferentiated Bone-marrow Stromal Cells into a Vein Graft Accelerates Sciatic Nerve Regeneration in Streptozotocin Induced Diabetic Rats
Current Neurovascular Research Cellular and Molecular Mechanisms Involved in the Action of Vitamin D Analogs Targeting Vitiligo Depigmentation
Current Drug Targets